Treatment of hypertension in the elderly after HYVET study results disclosure

Danuta Czarnecka; Jerzy Wiliński; Małgorzata Kloch-Badełek

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

4/2008
vol. 11

Send email

Copy url:

abstract:

Treatment of hypertension in the elderly after HYVET study results disclosure

Danuta Czarnecka

,

Jerzy Wiliński

,

Małgorzata Kloch-Badełek

Przew Lek 2008; 4: 54-60

Online publish date: 2008/09/26

View full text Get citation

Various clinical studies focusing on the treatment of hypertension in the very elderly (over 80 years old) have yielded inconclusive results of all-cause mortality. Results of the HYVET study prove that early and systematic therapy of hypertension with indapamide or indapamide and perindopril in this age group reduces the risk of all-cause mortality, stroke mortality, cardiovascular incidents and heart failure development. The treatment of hypertension demands a holistic approach to the patient regarding global cardiovascular risk and individualization of hypertensive therapy.

keywords:

Treatment of hypertension in the elderly after HYVET study results disclosure

Danuta Czarnecka , Jerzy Wiliński , Małgorzata Kloch-Badełek

hypertension, elderly, HYVET

Danuta Czarnecka

,

Jerzy Wiliński

,

Małgorzata Kloch-Badełek